Nationwide Children's Hematology/Oncology/BMT is committed to advancing both basic and clinical research. The division maintains active membership in the Children’s Oncology Group and the Pediatric Blood and Marrow Transplant Consortium, and is a research member of the International Blood and Marrow Transplant Registry. The division is also involved in other clinical research efforts aimed at improving bone marrow transplant outcomes. Hematology, Oncology and Blood and Marrow Transplant works hand-in-hand with the Center for Childhood Cancer and Blood Diseases to expand the understanding of childhood cancer and to improve strategies for its diagnosis and treatment.
Approximately 74 percent of eligible oncology patients are enrolled in clinical trials at Nationwide Children’s Hospital, making the division one of the leading cancer centers for clinical trial enrollment by the Children’s Oncology Group.